Skip to main content
. 2021 Apr 3;10(4):377. doi: 10.3390/antibiotics10040377

Table 1.

1H (500 MHz) and 13C (125 MHz) nuclear magnetic resonance (NMR) data of 1 and 2.

Position 1 (DMSO-d6) Position 2 (CDCl3)
δC, Type δH (J in Hz) δC, Type δH (J in Hz)
1 156.6, C 1 118.0, CH 6.94 (d, J = 8.5 Hz)
2 122.6, C 2 134.8, CH 7.72 (d, J = 8.5 Hz)
3 143.2, C 3 134.0, C
4 123.5, CH 6.28 (s) 4 156.9, C
4a 150.6, C 4a 121.6, C
4b 153.5, C 5 166.4, C
5 111.7, CH 5.90 (d, J = 2.0 Hz) 7 69.1, CH2 5.11 (s)
6 165.6, C 7a 125.9, C
7 101.3, CH 6.19 (d, J = 2.0 Hz) 8 121.2, CH 6.40 (s)
8 163.3, C 9 135.6, C
8a 109.7, C 10 117.8, CH 6.87 (s)
8b 114.1, C 11 147.4, C
9 45.6, C 11a 141.0, C
10 190.2, C 12a 154.0, C
11 167.5, C 13 64.3, CH3 3.91 (s)
12 19.8, CH3 2.10 (s) 1’ 190.7, C
1’/8’ 125.9, C 2’ 124.1, CH 6.66 (s)
2’/7’ 115.5, CH 6.15 (s) 3’ 158.8, C
3’/6’ 144.1, C 4’ 21.7, CH3 2.26 (s)
4’/5’ 131.0, C 5’ 28.3, CH3 2.01 (s)
4’a/4’b 137.3, C 1’’ 21.0, CH3 2.25 (s)
8’a/8’b 117.7, C
9’/10’ 19.9, CH3 1.34 (s)
3’/6’-OH 8.95 (s)
4’/5’-OH 9.00 (s)